RT @PanCAN@twitter.com
#PancChat Q12. @ASCO@twitter.com #GI23 data presented from the @IpsenGroup@twitter.com phase III NAPOLI 3 trial, evaluating the NALIRIFOX regimen showed positive results in overall survival for patients with previously untreated metastatic #pancreaticcancer.
http://pcan.at/2vaeny